Dvigatelj Asinhronnij Tip Ave 071 4s Uhl4

Costs and expenses Base metals costs were US$ 1.071 billion in 1Q15 (or US$ 1.465 billion including depreciation). After adjusting for the effects of higher volumes (US$ 5 million) and exchange rate variations (-US$ 80 million), costs decreased by US$ 59 million when compared to 4Q14. Tda6930xgeg smd p-dso-28 d/c0148 siemens t&r 320pcs tmp87ch29u-2403 smd tray toshiba factory sealed 450pcs tmp47c817f-hc11 smd tray toshiba factory sealed 400pcs.

Di shirainime kalian bisa mendownload anime batch dengan kualitas video mp4,mkv,360p,480p,720p,1080p bd: Eyeshield 21 sub indo batch, Eyeshield 21 batch subtitle indonesia, download Eyeshield 21 sub indo, Eyeshield 21 batch, Eyeshield 21 mp4 batch, Eyeshield 21 hd batch google drive, Eyeshield 21 samehadaku, Eyeshield 21 Meownime, Eyeshield 21. Eyeshield 21 Sub Indo, Eyeshield 21 Batch, Eyeshield 21 480p 720p 360p, Eyeshield 21 Mp4 Sub Indo, Eyeshield 21 MKV Sub Indo, Eyeshield 21 Subtitle Indonesia, Download Anime Eyeshield 21 Subtitle Indonesia, Eyeshield 21 Sub Indo Mp4 untuk HP, Android, Tablet dan lain sebagainya. Selamat menikmati link download Eyeshield 21 sub indo lewat google drive yang sudah tersedia juga link download format mp4,360p,480p,720p hanya di Kumanime. Download Eyeshield 21 Sub Indo Batch Link Download Batch Versi 480p - 4.9 GB (MP4) (01-50). Download dan Streaming Anime Eyeshield 21 Subtitle Indonesia BD dan Batch dengan ukuran 480p, 720p, 360p dalam format Mp4 dan MKV Google Drive, Kumpulbagi. Sinopsis: Awal dari Eyeshield 21 menceritakan seputar seorang remaja laki-laki lemah bernama Sena Kobayakawa yang memasuki sekolah pilihannya, SMA Deimon. Downlaod anime nonton online streaming Eyeshield 21 subtitle indonesia dan Eyeshield 21 sub indo mp4 3gp 480p 720p mkv episode 1-145 tamat bahasa indonesia AnimePack Streaming Anime Sub Indo Menu. Download eyeshield 21 sub indo 360p mkv free.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934       November 25, 2014 (Date of the earliest event reported)       Simulations Plus, Inc. (Exact name of registrant as specified in its charter)     California 001-320609 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Item 8.01     Other Events   On November 25, 2014, Simulations Plus, Inc., a California corporation (the 'Company'), held a conference call reporting its financial result for the fourth fiscal quarter and fiscal year ended August 31, 2014. The press release and the PowerPoint slides, which were used for this Conference Call, are attached herein as exhibits.

This report on Form 8-K (the 'Report'), including the disclosures set forth herein, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms 'anticipates,' 'expects,' 'estimates,' 'believes' and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements. 3 EX-99.1 2 simulations_8k-ex9901.htm PRESS RELEASE EXHIBIT 99.1 Simulations Plus Integrating Science and Software For Further Information: Simulations Plus, Inc.

42505 10 th Street West Lancaster, CA CONTACT: Simulations Plus Investor Relations Hayden IR Ms. Renee Bouche Mr. Cameron Donahue 661-723-7723 651-653-1854 renee@simulations-plus.com cameron@haydenir.com For Immediate Release: November 25, 2014 Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results Full Fiscal Year Pharmaceutical Software and Services Up 13.8%, Fourth Quarter Revenues up 27.4% LANCASTER, CA, November 25, 2014 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2014 fiscal year (FY14) and fourth quarter (4Q14) ended August 31, 2014.

Film caligula s miloj jovovich 2005 full. On September 2, 2014, Simulations Plus acquired Cognigen Corporation, a leading provider of pharmacometric modeling and simulation services and clinical pharmacology consulting for the pharmaceutical and biotechnology industries. Pursuant to the agreement, Cognigen has become a wholly owned subsidiary of Simulations Plus and is continuing to operate under the Cognigen name. The acquisition is expected to add approximately $5 million to the revenues of the combined company in the coming fiscal year.

As a result of the acquisition, the total number of Simulations Plus employees increased from 30 to 65. In 1997, Simulations Plus entered into a royalty agreement with Therapeutic Systems Research Laboratories (TSRL), pursuant to which royalties were paid to TSRL from revenues on each license for GastroPlus basic software. On May 15, 2014, the Company entered into a buyout agreement with TSRL. Under the terms of the Agreement, Simulations Plus will no longer pay royalties on each license of the GastroPlus software. The buyout of the prior agreement will be amortized at a constant rate of $150,000 per quarter until it is completely amortized, after which no further expense will be incurred. For most quarters, this will result in a savings over the royalty payments that would have been made in the past.